title: (99m)Tc-tetrofosmin as a prognostic agent?
authors.forename: Ichiro
authors.initials: I
authors.lastname: Matsunari
authors.forename: Junichi
authors.initials: J
authors.lastname: Taki
authors.forename: Kenichi
authors.initials: K
authors.lastname: Nakajima
authors.forename: Norihisa
authors.initials: N
authors.lastname: Tonami
mesh_terms: D002986:Clinical Trials as Topic; D003324:Coronary Artery Disease / Q000150:complications / Q000000981:diagnostic imaging* / Q000628:therapy; D004280:Dobutamine; D005080:Exercise Test / Q000379:methods; D006801:Humans; D009943:Organophosphorus Compounds; D015609:Organotechnetium Compounds; D011379:Prognosis; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D018570:Risk Assessment / Q000379:methods*; D012307:Risk Factors; D014665:Vasodilator Agents; D018487:Ventricular Dysfunction, Left / Q000000981:diagnostic imaging* / Q000209:etiology / Q000517:prevention & control
chemical_list: D009943:Organophosphorus Compounds; D015609:Organotechnetium Compounds; D019275:Radiopharmaceuticals; D014665:Vasodilator Agents; D004280:Dobutamine; C078700:technetium tc-99m tetrofosmin